Clinical Studies
1.
Garg S, Sarno G, Gutiérrez-Chico JL, García-García HM, Gomez-Lara J, Serruys PW. Five year
outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study.
EuroIntervention 2011; 6(9):1060-7
2.
Garg S, Serruys PW, Holmes DR Jr, Kappetein AP, van den Brand M, Mack M, Feldman T,
Morice MC, Ståhle E, Colombo A, van Dyck N, Leadley K, Morel MA, van Es GA, Mohr FW, Dawkins
KD. Combined Clinical and Angiographic Risk Assessment in Patients with Left Main Stem Disease
Treated with Percutaneous Coronary Intervention: A Sub-Study of the SYNTAX Trial.
EuroIntervention. In press.
3.
Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns R-J, Richardt G, Buszman P, Kelbæk
H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G,
Kornowski R, Ischinger T, Bartorelli A, Bressers M, van Remortel E, Ronden J, Windecker S. The
prognostic utility of the SYNTAX score for risk assessment in patients undergoing coronary
revascularization with second generation drug eluting stents: A sub-study of the randomized
RESOLUTE All Comers trial. J Am Coll Cardiol Intv. 2011; 4(4):432-441
4.
Garg S, Sarno G, Girasis C, Vranckx P, de Vries T, Swart M, Bressers M, García-García HM, van
Es GA, Räber L, Campo G, Valgimigli M, Dawkins KD, Windecker S, Serruys PW. A patient level pooled
analysis assessing the impact of the SYNTAX score on 1-year clinical outcomes in 6,508 patients
enrolled in contemporary coronary stent trials. J Am Coll Cardiol Intv. 2011; 4(6):645-653
5.
Garg S, Wykrzykowska JJ, Serruys PW, de Vries T, Buszman P, Trznadel S, Linke A, Lenk K,
Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice MC, di Mario C, Tyczynski P, van Geuns RJ,
Eerdmans P, van Es GA, Meier B, Juni P, Windecker S. The outcome of bifurcation lesion stenting
using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent
with a durable polymer. EuroIntervention. 2011; 6(8):928-935
6.
Garg S, Sarno G, Serruys PW, Rodriguez A, Bolognese L, Anselmi M, De Cesare N, Colangelo
S, Moreno R, Gambetti S, Monti M, Bristot L, Bressers M, García-García HM, Parrinello G, Campo G,
Valgimigli M. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute
ST-elevation myocardial infarction undergoing primary PCI: A sub-study of the STRATEGY and MULTISTRATEGY trials. J Am Coll Cardiol Intv. 2011; 4(1):66-75
7.
Garg S, Sarno G, García-García HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW. A
new tool for the risk stratification of patients with complex coronary artery disease: The Clinical
SYNTAX score. Circ Cardiovasc Interv. 2010; 3(4):317-326
8.
Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbæk H, van Boven AJ,
Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, Dimario C, Manoharan G, Kornowski R,
Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S.
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Eng J Med. 2010;
363(2):123-135
9.
Garg S, Sarno G, Serruys PW, de Vries T, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F,
Corti R, Wijns W, Morice MC, Di Mario C, van Geuns RJ, Eerdmans P, van Es GA, Meier B, Jüni P,
Windecker S. The twelve month outcomes of a biolimus eluting stent with a biodegradable polymer
compared with a sirolimus eluting stent with a durable polymer. EuroIntervention. 2010; 6(2): 233239
10.
Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Bressers M, García-García HM, van Es GA,
Serruys PW. The SYNTAX score revisited: a new assessment of the SYNTAX score reproducibility.
Catheter Cardiovasc Interv. 2010; 75(6):946-952.
11.
Garg S, Serruys PW, Miquel- Hébert K. Four year clinical follow up of the XIENCE V
everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery
lesions: The SPIRIT II Trial. Catheter Cardiovasc Interv. 2011; 77(7):1012-1017
12.
Garg S, Serruys PW, Onuma Y, Dorange C, Veldhof S, Miquel-Hébert K, Sudhir K, Boland J,
Huber K, Garcia E, te Riele JA on behalf of the SPIRIT II Investigators. Three year clinical follow up of
the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo
coronary artery lesions. The SPIRIT II Trial. J Am Coll Cardiol Intv. 2009; 2(12):1190-1198
13.
Garg S, Saha A, Clark A. Is sensible use being made of an inpatient Holter monitoring and
transthoracic echocardiogram service within acute medicine? Clin Med 2006; 6(6):586-591
14.
Girasis C, Garg S, Räber L, Sarno G, Morel MA, Garcia-Garcia HM, Lüscher TF, Serruys PW,
Windecker S, SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical
outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimuseluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial.
Eur Heart J. 2011; 32(24): 3115-3127
15.
Wykrzykowska JJ, Garg S, Onuma Y, de Vries T, Goedhart D, Morel, van Es GA, Buszman P,
Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P,
Windecker S, Serruys PW. Value of Age, Creatinine and Ejection Fraction (ACEF score) in assessing
risk in patients undergoing percutaneous coronary interventions in an “all-comers” LEADERS trial.
Circ Cardiovasc Interv. 2011; 4(1):47-56
16.
Sarno G, Garg S, Gomez-Lara J, García-García HM, Ligthart J, Bruining N, Onuma Y, Witberg K,
van Geuns R-J, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P,
van ES G, Boersma E, van der Giessen W, Serruys PW. Intravascular ultrasound radiofrequency
analysis after optimal coronary stenting with initial quantitative coronary angiography guidance (An
ATHEROREMO sub-study). EuroIntervention. 2011; 6(8):977-984
17.
Legrand VM, Garg S, Serruys PW, Virtanen K, Szurawitzki G, Voudris V, Fontanelli A, Endersen
K, Kranjec I, Rademaker T, Stefanadis C, Wittebols K. Influence of age on the clinical outcomes of
coronary revascularization for the treatment of patients with multivessel de novo coronary artery
lesions. Sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent: Insight from
the multicenter randomized Arterial Revascularization Therapy Study Part I (ARTS-I) and Part II
(ARTS-II). EuroIntervention. 2011; 6(7):838-845
18.
Vranckx P, Garg S, Serruys PW. Percutaneous mechanical support for cardiogenic shock
complicating ACS. Acute Coronary Syndromes 2011;10(1):2–9
19.
Bourantas CV, Garg S, Naka KK, Thury A, Hoye A, Michalis LK. Focus on the research utility of
intravascular ultrasound - comparison with other invasive modalities. Cardiovasc Ultrasound. 2011;
9(1): 2
20.
Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel, van Es GA, Buszman P, Linke A,
Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, di Mario C, van Geuns RJ, Juni P,
Windecker S, Serruys PW. Value of the SYNTAX score (SX) for risk assessment in the “all-comers”
population of the randomized multicenter LEADERS trial. J Am Coll Cardiol. 2010; 56(4): 272-277
21.
Okamura T, Garg S, Gutierrez-Chico JL, Shin ES, Onuma Y, García-García HM, Rapoza RJ,
Sudhir K, Regar E, Serruys PW. In-vivo evaluation of stent strut distribution patterns in the
bioabsorbable everolimus-eluting device: An OCT ad hoc analysis of the Revision 1.0 and Revision 1.1
stent design in the ABSORB clinical trial. EuroIntervention. 2010; 5(8):932-938
22.
Serruys PW, Garg S, Abizaid A Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J,
Hauptmann KE, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, den Drijver
AM, Otake H, Meredith L, Toyloy S, Fitzgerald P. A randomised comparison of novolimus-eluting and
zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.
EuroIntervention. 2010; 6(2): 195-205
23.
Sarno G, Garg S, Onuma Y, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns
W, Morice MC, di Mario C, van Geuns RJ, Eerdmans P, García-García HM, van Es GA, Goedhart D, de
Vries T, Jüni P, Meier B, Windecker S, Serruys P. The impact of body mass index on the one year
outcomes of patients treated by PCI with biolimus- and sirolimus- eluting stents in the LEADERS trial.
Does the obesity paradox exist? Am J Cardiol. 2010;105(4):475-479
24.
Sarno G, Garg S, Onuma Y, Gutiérrez-Chico JL, van den Brand M, Rensing B, Morel MA,
Serruys PW. The impact of completeness of revascularization on the five-year outcome in PCI and
CABG patients (from the ARTS-II study). Am J Cardiol. 2010;106 (10):1369–1375
25.
Sarno G, Garg S, Onuma Y, Girasis C, Tonino P, Morel MA, van Es GA, Pijls N, Serruys PW.
Bifurcation lesions: Function assessment by fractional flow reserve vs. anatomical assessment using
conventional and dedicated bifurcation quantitative coronary angiogram. Catheter Cardiovasc
Interv. 2010; 76 (6):817-823
26.
Wykrzykowska J, Garg S, Onuma Y, de Vries T, Morel MA, van Es GA, Buszman P, Linke A,
Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, DiMario C, van Geuns RJ, Juni P,
Windecker S, Serruys PW. Implantation of the biodegradable polymer biolimus eluting stent in
patients with high SYNTAX score is associated with decreased cardiac mortality compared to
permanent polymer sirolimus eluting stent. Two year follow-up results from the all-comers LEADERS
trial. EuroIntervention. 2011: 7(5): 605-613
27.
García-García HM, Garg S, Brugaletta S, Morocutti G, Ratner RE, Kolatkar NS, Kravitz BG,
Miller DM, Huang C, Nesto RW, Serruys PW and the APPROACH study group. Evaluation of In-stent
Restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On
Atherosclerosis in Diabetes Patients with Cardiovascular History). Int J Cardiovasc Imaging.
2012;28(3):455-465
28.
Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW.
Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary
coronary stent trials: impact on outcome reporting. Heart. 2012;98(19):1424-30
29.
Vranckx P, Boersma E, Garg S, Valgimigli M, Vans Es GA, Goedhart D, Serruys PW.
Cardiovascular Risk profile of patients included in stent trials: A meta-analysis of individual patient
data from randomized clinical trials. Insights from 33 prospective stent trials in Europe.
EuroIntervention. 2011; 7(7): 859-71
30.
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C,
Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP; on behalf of the ARTS
II Investigators. Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study
of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery
lesions. J Am Coll Cardiol. 2010; 55(11): 1093-101
31.
Serruys PW, Onuma Y, Garg S, Sarno G, Van den Brand M, Kappetein AP, van Dyck N, Mack
MJ, Holmes Jr DR, Feldman TE, Morice MC, Colombo A, Bass EJ, Leadley K, Dawkins K, van Es GA,
Morel MA, Mohr F. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009;
5(1): 50-56.
32.
Shen ZJ, García-García HM, Garg S, Onuma Y, Schenkeveld L, van Domburg RT, Serruys PW;
on behalf of the Interventional Cardiologists at Thoraxcentre in 2000–2003. Five-year clinical
outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: Insights
from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
Catheter Cardiovasc Interv. 2009; 74(7): 979-986
33.
Shin ES, García-García HM, Garg S, Serruys PW. A comparison between plaque-based and
vessel-based measurement for plaque component using volumetric intravascular ultrasound
radiofrequency data analysis. Int J Cardiovasc Imaging. 2011; 27(4): 491-497
34.
Brugaletta S, García-García HM, Garg S, Gomez-Lara J, Diletti R, Onuma Y, van Geuns RJ,
McClean D, Dudek D, Thuesen L, Chevalier B, Windecker S, Whitbourn R, Dorange C, Miquel-Hebert
K, Sudhir K, Ormiston JA, Serruys PW. Temporal changes of coronary artery plaque located behind
the struts of the everolimus eluting bioresorbable vascular scaffold. Int J Cardiovasc Imaging. 2011;
27(6): 859-866
35.
Shin ES, García-García HM, Garg S, Park J, Kim SJ, Serruys PW. The assessment of Shin's
method for the prediction of creatinine kinase-MB elevation after percutaneous coronary
intervention: an intravascular ultrasound study. Int J Cardiovasc Imaging. 2011; 27(6): 883-892
36.
Shin ES, García-García HM, Garg S, Ligthart J, Thuesen L, Dudek D, Ormiston JA, Serruys PW.
Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with
bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study. Int J
Cardiovasc Imaging. 2011; 27(7): 931-937
37.
Onuma Y, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW. Five-year clinical outcomes of
diabetic patients in the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting
stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol
Intv. 2011; 4(3): 317-323
38.
Gomez-Lara J, Heo JH, Brugaletta S, Garg S, Garcia-Garcia HM, van Geuns RJ, Silber S,
Windecker S, Serruys PW. Risk of target lesion failure in relationship to vessel angiographic geometry
and stent conformability using the second generation of drug-eluting stents. Am Heart J. 2011;
162(6):1069-1079
39.
Sarno G, Räber L, Onuma Y, Garg S, Brugaletta S, van Domburg RT, Pilgrim T, Pfäffli N,
Wenaweser P, Windecker S, Serruys PW. Impact of Body Mass Index on the Five year Outcome of
Patients Having Percutaneous Coronary Interventions with Drug-eluting Stents. Am J Cardiol. 2011.
108(2):195-201
40.
Gomez-Lara J, García-García HM, Onuma Y, Garg S, Regar E, De Bruyne B, Windecker S,
McClean D, Thuesen L, Dudek D, Koolen J, Whitbourn R, Smits P, Chevalier B, Dorange C, Veldhof S ,
Morel MA, deVries T, Ormiston JA. A comparison of the conformability of everolimus-eluting
bioresorbable vascular scaffolds to metal platform coronary stents. J Am Coll Cardiol Intv.
2010;3(11):1190-1198
41.
Sarno G, Onuma Y, García-García HM, Garg S, Regar E, Thuesen L, Dudek D, Veldhof S,
Dorange C, Ormiston JA, Serruys PW. IVUS radiofrequency analysis in the evaluation of the dynamic
changes of the polymeric struts of the bioabsorbable everolimus-eluting device during the
bioabsorption process. Catheter Cardiovasc Interv. 2010;75(6):946-952
42.
García-García HM, Gomez-Lara J, Gonzalo N, Garg S, Shin E, Goedhart D, Serruys PW. A
comparison of the distribution of necrotic core in bifurcation and non-bifurcation coronary lesions:
an in vivo assessment using intravascular ultrasound radiofrequency data analysis. EuroIntervention
2010; 6(3):321-327
43.
Gomez-Lara J, Diletti R, Brugalleta S, Garg S, Onuma Y, Gogas W, van Geuns RJ, Dorange C,
Veldhof S, Whitbourn R, Windecker S, García-García HM, Regar E, Serruys PW. A comparative
assessment by optical coherence tomography of the performance of the first and second generation
of the everolimus-eluting bioresorbable vascular scaffolds. Eur Heart J. 2011; 32(3): 294-304
44.
Sarno G, Bruining N, Onuma Y, Garg S, Brugaletta S, De Winter S, Regar E, Thuesen L, Dudek
D, Veldhof S, Dorange C, García-García HM, Ormiston JA, Serruys PW. Morphological and functional
evaluation of the bioresorption of the bioresorbable everolimus-eluting vascular scaffold using IVUS,
echogenicity and vasomotion testing at two year follow-up: a patient level insight into the ABSORB a
clinical trial. Int J Cardiovasc Imaging. 2012;28(1):51-8
45.
Brugaletta S, Garcia-Garcia HM, Diletti R, Gomez-Lara J, Garg S, Onuma Y, Shin ES, van Geuns
RJ, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn R, Dorange C,
Veldhof S, Rapoza R, Sudhir K, Bruining N, Ormiston JA, Serruys PW. Comparison between the first
and second generation bioresorbable vascular scaffolds: a six month virtual histology study.
EuroIntervention 2011;6(9):1110-6
46.
Gutiérrez-Chico J-L, Serruys PW, Girasis C, Garg S, Onuma Y, Brugaletta S, García-García HM,
van Es GA, Regar E. Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a
head-to-head comparison between QCA, IVUS and OCT. Int J Cardiovasc Imaging. 2012; 28(3): 467478
47.
Onuma Y, Girasis C, Piazza N, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van
Domburg R, Serruys PW; Interventional Cardiologists at Thoraxcenter 2000–2005. Long-term clinical
results following stenting of the left main stem insights from RESEARCH (Rapamycin-Eluting Stent
Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam
Cardiology Hospital) Registries. J Am Coll Cardiol Intv. 2010;3(6): 584-594
48.
Magro M, Nauta S, Simsek C, Onuma Y, Garg S, van der Heide E, van der Giessen W, Boersma
H, van Domburg RT, van Geuns RJ, Serruys PW. Value of the SYNTAX score in patients treated by
primary percutaneous coronary intervention for acute ST elevation myocardial infarction - the MI
SYNTAXscore study. Am Heart J. 2011; 161(4):771-781
49.
Gutiérrez-Chico JL, García-García HM, Ligthart J, Bol-Raap G, Garg S, Bekkers JA, Serruys PW.
How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic
dissection? EuroInter 2011; 7(5): 638-646
50.
Bourantas CV, Loh HP, Bragadeesh T, Rigby AS, Lukaschuk EI, Garg S, Tweddel AC, Alamgir
FM, Nikitin NP, Clark AL, Cleland JGF. Relationship between right ventricular volume measured by
cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure. Eur J Heart
Fail. 2011;13(1) :52-60
51.
García-García HM, Klauss V, Gonzalo N, Garg S, Onuma Y, van Es GA, Goedhart D, Hamm CW,
Wijns W, Zalewski A, Serruys PW on behalf of the IBIS-2 Investigators. Relationship between
cardiovascular risk factors and biomarkers with necrotic core and atheroma size: a serial
intravascular ultrasound radiofrequency data analysis. Int J Cardiovasc Imaging. 2011. In press.
52.
Dominici M, Diletti R, Milici C, Bock C, Garg S, DE Paolis M, Ambrosio G, Boschetti E. Left
Radial versus Right Radial Approach for Coronary Artery Catheterization: A Prospective Comparison.
J Interv Cardiol. 2012;25(2):203-9
Reviews
1.
Garg S, Serruys PW, An update on drug-eluting stents. Curr Treat Options Cardiovasc Med.
2012 In press.
2.
Garg S, Serruys PW, Coronary Stents – Current status. J Am Coll Cardiol. 2010;56(10): S1-S42
3.
S78
Garg S, Serruys PW, Coronary Stents – Looking Forward. J Am Coll Cardiol. 2010;56(10): S43-
4.
Garg S, Stone GW, Kappetein AP, Sabik J, Simonton C, Serruys PW. Clinical and angiographic
risk assessment in patients with left main stem lesions. J Am Coll Cardiol Intv. 2010;3(9): 891-901
5.
Holmes DR, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T,
Moliterno DJ. Stent Thrombosis. J Am Coll Cardiol. 2010; 56(17):1357-1365
6.
Garg S, Serruys PW. Biodegradable stents and non-biodegradable stents. Minerva
Cardioangiol. 2009; 57(5):537-65
7.
Garg S, Hoye A. Percutaneous Coronary Intervention for de novo Bifurcation Lesions.
Interventional Cardiology. 2006:30-32.
8.
Magro M, Garg S, Serruys PW. Revascularization treatment of stable coronary artery disease.
Expert Opin Pharmacother.2011;12(2):195-212
9.
Pernicova I, Garg S, Bourantas CV, Alamgir F, Hoye A. Takotsubo Cardiomyopathy: a review
of the literature. Angiology. 2010; 61(2):166-173
10.
Serruys PW, Garg S. Clinical implications of the SYNTAX trial. Interventional Cardiology. 2009
(4) 41-45.
11.
Bourantas CV, Naka KK, Garg S, Thackray ST, Papadopoulos D, Alamgir MF, Hoye A, Michalis
LK. Clinical indications for intracoronary ultrasound Imaging. Echocardiography. 2010; 27(10):128290
12.
Sarno G, Okamura T, Gomez-Lara J, Garg S, Girasis C, Kopia G, Pomeranz M, Easterbrook W,
van Geuns R-J, van der Giessen W, Serruys PW. The coronary Stent-On-A-Wire. EuroIntervention.
2010; 6(3):413-417
Editorials
1.
Garg S, Serruys PW. Drug-eluting stents: a reappraisal. Heart. 2010; 96(7):489-93
2.
Garg S, Serruys PW. A review of the benefits of and safety concerns associated with drug
eluting coronary stents. Expert Rev Cardiovasc Ther. 2010; 8(3):449-70
3.
Garg S, Duckers HJ, Serruys PW. Endothelial progenitor cell capture stents: will this
technology find its niche in contemporary practice? Eur Heart J. 2010;31(9):1032-5
4.
Garg S, Serruys PW. Drug eluting stents are safe. Clin Pharmacol Ther. 2009; 86(2):130-2
5.
Garg S, Serruys PW. Interventional cardiology: Coronary angioplasty: Do we need to
euroSCORE? Nat Rev Cardiol. 2009; 6(4): 267-268.
6.
Garg S, Serruys PW. Mediations on secondary revascularisation in the aftermath of the
SYNTAX trial. EuroIntervention. 2009; 5 (supplement D):D14-20.
7.
Serruys PW, Garg S. PCI for all complex coronary artery disease: triple vessel and/or left
main stem disease. Yes? No? Don't know? Rev Esp Cardiol. 2009; 62(7):719-25
Guidelines
1.
Wijns W, Kolh P, Danchin N, DiMario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J,
Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini F,
Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial
revascularization: the task force on myocardial revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 2010;
31:2501-2555
2.
Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and
the European Association for Cardio-Thoracic Surgery (EACTS); European Association for
Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization. Eur J
Cardiothorac Surg. 2010 Sep; 38 Suppl: S1-S52
Correspondence
1.
Garg S, Garg S. Revascularisation in patients with mental illness. Br J Psychiatry
2011;199:252-3
2.
Garg S, Rademaker T, Serruys PW. Correspondence fractional flow reserve for guiding PCI. N
Engl J Med 2009; 360(19):2024-2027
Book Chapters
1.
Garg, S, Wykrzykowska J, Serruys PW (2010). Stable angina: medical therapy vs. PCI vs.
CABG. In: Thomas M, Redwood SR, Curzen N (eds.) Oxford Textbook of Interventional Cardiology.
Oxford: Oxford University Press. pp221-34.
2.
Garg S, Serruys PW (2011). Individualised assessment for percutaneous or surgical
revascularisation. In: Topol E, Ternstein P (eds) Textbook of Interventional Cardiology, 6th Edition.
Oxford: Elsevier.
3.
Garg S, Magro M, Serruys PW (2011). Drug-eluting stents. In: Ducheyne P, Healy KE,
Hutmacher DW, Grainger DW , Kirkpatrick C J (eds) Comprehensive Biomaterials, Vol 6, pp. 427-448
Oxford: Elsevier.
4.
Garg, S, Wykrzykowska J, Serruys PW (2011). Percutaneous Coronary Intervention In: Tse HF,
Lip GYH, Coats A (eds) Oxford Desk Reference--Cardiology. Oxford: Oxford University Press.
5.
Garg S, Räber L, Serruys PW, Windecker (2012). Coronary Artery Stenting. In: Eeckhout E,
Serruys PW, Wijns W, Vahanian A, van Sambeek M (eds) Percutaneous Interventional Cardiovascular
Medicine. Paris: Europa Edition Publishing.
6.
Garg S, Holmes DR Jr (2012). Functional evaluation and risk stratification. In: Eeckhout E,
Serruys PW, Wijns W, Vahanian A, van Sambeek M (eds) Percutaneous Interventional Cardiovascular
Medicine. Paris: Europa Edition Publishing.
7.
Garcia-Garcia HM, Garg S, Diletti R, Brugaletta R, Serruys PW (In press). Research Utility of
Intravascular Ultrasound. In: Lampros M, Fotiadis D, Naka K, Bourantas C, Tsakanikas V (eds)
Intravascular Imaging - Current Applications and Research Developments. Hershey PA: IGI Global.
8.
Bourantas CV, Naka KK, Garg S, Alamgir FM, Hoye A, Michalis L (In press). Implications of
intracoronary ultrasound imaging for clinical practice. In: Lampros M, Fotiadis D, Naka K, Bourantas
C, Tsakanikas V (eds) Intravascular Imaging - Current Applications and Research Developments.
Hershey PA: IGI Global.
9.
Siogkas P, Fotiadis D, Bourantas C, Tweddel A, Garg S, Michalis L, Koutsouris D. (In press).
Analysis of existing fusion methodologies. In: Lampros M, Fotiadis D, Naka K, Bourantas C,
Tsakanikas V (eds) Intravascular Imaging - Current Applications and Research Developments.
Hershey PA: IGI Global.
Case reports
1.
Anderson SG, Lai TK, Newton T, Garg S. Roller coasters a source of fun an tears. Emergency
Medicine 2013. In press
2.
Cunnington C, Garg S, Balachandran KP. Seizure-associated takotsubo cardiomyopathy
presenting with unheralded ventricular fibrillation. Int J Cardiol. 2012 15;162(1):e21-3
3.
Garg S, Bourantas CV, Thackray S, Alamgir MF. Echocardiographic identification of
ventricular septal rupture caused by acute stent thrombosis. J Clin Ultrasound. 2010; 38(4): 218-221
4.
Garg S, Schultz C, Sarno G, Serruys PW. How should I treat a tortuous calcified right coronary
artery? EuroIntervention. 2010; 6(1):161-7
5.
Garg S, Serruys PW, van der Ent M, Schultz C, Mastik F, van Soest G, van der Steen AF, Wilder
MA, Muller JE, Regar E. First use in patients of a combined near infra-red spectroscopy and intravascular ultrasound catheter to identify composition and structure of coronary plaque.
EuroIntervention. 2010; 5(6):755-756
6.
Garg S, Bourantas CV, Nair R, Alamgir F. Carcinoid syndrome diagnosed by
echocardiography. Int J Cardiol. 2009 – published online ahead of print
7.
Garg S, Bourantas CV, Thackray S, Alamgir F. Left main occlusion diagnosed on CT chest. Br J
Cardiol. 2008; 15: 269-70.
8.
Garg S, Bourantas C, Thackray S. Angiographically occult coronary artery dissection poststenting imaged using optical coherence tomography. Heart. 2008; 94(3):335.
9.
Garg S, Nair R, Alamgir MF. Palliative percutaneous coronary intervention with the
PRESILLION stent in an elderly patient. Cardiac & Vascular Update. 2008; 2:4-6.
10.
Garg S, Perez L, Griffin S. Type A aortic dissection presenting as complete heart block.
Resuscitation. 2007; 75(3):398-99
11.
Garg S, Walters M, Khan A. External cardiac pacing causing Staphylococcus aureus
septicaemia. Resuscitation. 2006; 69(2):169-70
12.
Onuma Y, Garg S, Okamura T, Ligthart J, Van Geuns RJ, De Feijter P, Serruys PW, Tamai H.
Ten-year follow-up of the IGAKI-TAMAI stent. A post-humous tribute to the scientific work of Dr.
Hideo Tamai. Eurointervention. 2009; 5 (Suppl F) F109-F111
13.
Wentzel JJ, van der Giessen AG, Garg S, Schultz C, Mastik F, Gijsen FJH, Serruys PW, van der
Steen AFW, Regar E. 3D distribution of lipid rich plaque in human coronary artery as assessed by
fusion of NIR-IVUS and MSCT. Circ Cardiovasc Imaging. 2010; 3(6):e6-e7
14.
Sarno G, Schultz C, Garg S, Ligthart J, Garcia-Garcia HM, Serruys PW. How should I treat a
complex post CABG patient? EuroIntervention. 2009; 5(5):627-632.
15.
Schultz C, Serruys PW, van der Ent M, Lighthart J, Mastik F, Garg S, Muller JE, Wilder MA, van
der Steen A, Regar E. First in man clinical use of a combined near infra-red spectroscopy and intravascular ultrasound - a potential key to predict distal embolization and no reflow? J Am Coll Cardiol.
2010; 56(4): 314